Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 12
Submit an article Journal homepage
510
Views
21
CrossRef citations to date
0
Altmetric
Neurology

Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses

Aseel Bin SawadMCPHS University, Boston, MA, USA; ;Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6620-0716
ORCID Icon,
Enrique Seoane-VazquezMCPHS University, Boston, MA, USA; Correspondence[email protected]
,
Rosa Rodriguez-MonguioUniversity of Massachusetts Amherst, Amherst, MA, USA;
&
Fatema TurkistaniMCPHS University, Boston, MA, USA; ;Taibah University, Medina, Kingdom of Saudi Arabia
Pages 1969-1974 | Received 02 Apr 2016, Accepted 04 Aug 2016, Published online: 07 Sep 2016

References

  • Lutton JD, Winston R, Rodman TC. Multiple sclerosis: etiological mechanisms and future directions. Exp Biol Med (Maywood) 2004;229:12-20
  • Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52
  • Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-87
  • Hafler DA, Weiner HL. Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev 1995;144:75-107
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-52
  • Rudick R, Antel J, Confavreux C, et al. Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996;40:469-79
  • Rudick R, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997;42:379-82
  • Cutter GR, Baier ML, Rudick RA, et al. Development of a Multiple Sclerosis Functional Composite as a clinical trial outcome measure. Brain 1999;122(Pt 5):871-82
  • Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999;5:244-50
  • Patzold T, Schwengelbeck M, Ossege LM, et al. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand 2002;105:164-8
  • Ozakbas S, Cagiran I, Ormeci B, Idiman E. Correlations between Multiple Sclerosis Functional Composite, Expanded Disability Status Scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci 2004;218:3-7
  • Ozakbas S, Ormeci B, Idiman E. Utilization of the Multiple Sclerosis Functional Composite in follow-up: relationship to disease phenotype, disability and treatment strategies. J Neurol Sci 2005;232:65-9
  • Kragt JJ, van der Linden FA, Nielsen JM, et al. Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 2006;12:594-8
  • Pascual AM, Bosca I, Coret F, et al. Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale. Eur J Neurol 2008;15:284-8
  • Hoogervorst EL, Kalkers NF, van Winsen LML, et al. Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis. Mult Scler 2001;7:335-9
  • Hoogervorst EL, Kalkers NF, Uitdehaag BM, Polman CH. A study validating changes in the Multiple Sclerosis Functional Composite. Arch Neurol 2002;59:113-16
  • Fox EJ, Sullivan HC, Gazda SK, et al. A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis. Eur J Neurol 2012;19:307-11
  • Goodkin DE. EDSS reliability. Neurology 1991;41:332
  • Polman CH, Rudick RA. The Multiple Sclerosis Functional Composite: a clinically meaningful measure of disability. Neurology 2010;74(Suppl 3):S8-S15
  • Schwid SR, Goodman AD, Apatoff BR, et al. Quantitative measures are more sensitive to worsening neurological function in a prospective multiple sclerosis study. Ann Neurol 1998;44:483
  • Ostberg A, Pittas F, Taylor B. Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status. Intern Med J 2005;35:382-7
  • Bosma LV, Kragt JJ, Brieva L, et al. The search for responsive clinical endpoints in primary progressive multiple sclerosis. Mult Scler 2009;15:715-20
  • Pilutti LA, Lelli DA, Paulseth JE, et al. Effects of 12 weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study. Arch Phys Med Rehabil 2011;92:31-6
  • Goodkin DE, Rudick RA, VanderBrug Medendorp S, et al. Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 1995;37:30-40
  • Rudick RA, Lee JC, Simon J, et al. Defining interferon beta response status in multiple sclerosis patients. Ann Neurol 2004;56:548-55

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.